S9 Ep24: FDA Approval Insights: Talquetamab in Relapsed/Refractory Multiple Myeloma
Sep 7, 2023
15:27
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Minnema discusses the FDA approval of talquetamab in patients with relapsed/refractory multiple myeloma, key data from the MonumenTAL-1 trial, and the importance of designing clinical trials to address unmet patient needs.
OncLive® On Air